Generally, proteolytic degradation of extra-cellular matrix (ECM) is mediated by MMPs, with MMP-2 and MMP-9 playing a critical role in prostate cancer progression [43,44,45]. This evidence concerns the gene MMP2 and prostate carcinoma.